|
| |
Image Results
Loading...
Loading...
Mylan Pharmaceuticals Global Marketing Pages on BioPortfolio:
|
BioPortfolio - Linezolid
Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R ) ... Pharmacia is a top-tier global pharmaceutical company, with a leading ...
http://www.bioportfolio.com/indepth/Linezolid.html...
|
BioPortfolio Limited Pharma Generic League - Market Analysis and ...
5.13.6 Phase IV Post-Marketing Study to Investigate Risk of Melanoma .... 10.7.3 Actavis Establishes Global Hospital Business Unit (GHBU) ... 13.4 Mylan's
Pharmaceuticals Product Porfolio Expands Significantly ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_2.html...
|
BioPortfolio - UCB Pharma
Pharmacometrics, Department of Global Exploratory Development, UCB Pharma ... Press Releases on UCB Pharma: BioPortfolio Logo. Mylan Reports Third Quarter ...
http://www.bioportfolio.com/biocorporate/10415-UCB+Pharma.ht...
|
Consolidation in the Generic Pharmaceutical Industry
In 2006, global sales of generic pharmaceuticals were $ 77 billion. ... shifting from single country marketing strategies through mergers and take-overs. ...
Kyowa, Mallinckrodt, Merck, Mylan, Nichiiko, Nicholas Piramal, Novo Nordisk, ...
http://www.bioportfolio.com/cgi-bin/acatalog/Consolidation_i...
|
Central and Eastern European CEE Developing Markets for ...
A forecast of the global pharmaceutical market from 2006-2011, with key issues ... Mylan Laboratories. Nicholas Piramal. Nizpharm. Novartis. Novo Nordisk ...
http://www.bioportfolio.com/cgi-bin/acatalog/Central_and_Eas...
|
5th Annual Biosimilars Conference Innovations, Developments, and ...
Rasmus Rojkjaer, Vice President, Head of Global Biologics R&D, Mylan GmbH .... Director, Tikhe Pharma Former Global Head of Marketing and Medical, Sandoz ...
http://www.bioportfolio.com/cgi-bin/acatalog/5th-Annual-Bios...
|
Achieving success in the Developing Asian Pharmaceutical Sector ...
MSD Korea. Mylan Laboratories. Nicholas Piramal. Nizpharm. Novartis. Novo Nordisk. Nycomed. Omnicare CR. Otechestvennye Lekarstiva. Otsuka Pharmaceutical
...
http://www.bioportfolio.com/cgi-bin/acatalog/Achieving_succe...
| Results from other life science and pharmaceutical sites:
Cephalon | Cephalon and Eurand File Patent Infringement Lawsuit ...
26 Nov 2008 ... The Mylan ANDA alleges that the AMRIX patent will not be ... Concurrent with the patent protection described above, Cephalon has a three-year period of marketing
exclusivity ... Eurand is a specialty pharmaceutical company that develops, ...
Eurand is a global company with facilities in the U.S. and ...
http://www.cephalon.com/media/news-releases/by-product/...
|
Mylan Laboratories Inc. Announces Management of Specialty Business ...
2 Oct 2007 ... Prior to joining Mylan, Dr. Myers served as Global Director Cardiovascular at ... marketing, business development and government affairs. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=71849...
|
AstraZeneca International - pharmaceutical company, prescription ...
AstraZeneca International - A global pharmaceutical company .... AstraZeneca will pay for development and marketing costs. ... in New York against Mylan
Laboratories Inc. and Mylan Pharmaceuticals Inc. (Mylan) for patent infringement
. ...
http://www.astrazeneca.com/media/latest-press-releases/2000/...
|
Mylan Laboratories Inc. Announces Appointment of Patrick Vink...
26 Feb 2008 ... Mr. Vink comes to Mylan with 20 years of experience in the global pharmaceuticals industry including leadership roles at companies such as ...
http://www.biospace.com/news_story.aspx?NewsEntityId=87245...
|
Mylan Laboratories Launches Amlodipine Besylate Tablets and Has ...
Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL ...
http://www.prnewswire.com/news-releases/mylan-laboratories-l...
|
AstraZeneca International - pharmaceutical company, prescription ...
AstraZeneca International - A global pharmaceutical company ... On August 4, 2003 Mylan Pharmaceuticals announced it had begun sale of the 10mg and 20mg ...
development, manufacture and marketing of prescription pharmaceuticals and the
...
http://www.astrazeneca.com/media/latest-press-releases/2003/...
|
Forest Laboratories, Inc. and Mylan Laboratories Inc. Get FDA ...
3 Dec 2007 ... Forest licensed nebivolol from Mylan in January 2006 and has responsibility for all sales and marketing as well as current and future development programs. ...
a robust product pipeline and a global commercial footprint ...
http://www.biospace.com/news_story.aspx?NewsEntityId=79120...
|
AstraZeneca International - pharmaceutical company, prescription ...
AstraZeneca International - A global pharmaceutical company ... a lawsuit in New York against Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. (Mylan) ...
http://www.astrazeneca.com/media/latest-press-releases/2000/...
|
The global biopharma industry and the rise of Indian drug ...
Pricing pressures, safety recalls and marketing scandals also challenge an industry .... Firms in this group include Teva, Mylan Laboratories, Actavis,
..... Will India Become the Global Centre for Pharmaceutical Research &
Development? ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1896171/...
|
AstraZeneca International - pharmaceutical company, prescription ...
AstraZeneca International - A global pharmaceutical company ... DAMAGES IN PATENT INFRINGEMENT LAWSUIT AGAINST MYLAN PHARMACEUTICALS AstraZeneca announced
today ... and make its final decision on granting marketing approval for CRESTOR
. ...
http://www.astrazeneca.com/media/latest-press-releases/2003/...
|
|
